FDA Drug Application (040872) for PHENTERMINE RESIN COMPLEX by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number040872
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
DosageEQ 15MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePHENTERMINE RESIN COMPLEX
Active IngredientPHENTERMINE RESIN COMPLEX

Active IngredientCount
List of drugs with Active Ingredient PHENTERMINE RESIN COMPLEX3


Back to FDA Applications sponsored by LANNETT HOLDINGS INC